{{ subpage.title }}

The Graphic Truth: The unequal road to herd immunity

When will we return to a pre-pandemic normal by achieving COVID-19 herd immunity? Well, that depends where you live. While a host of wealthy nations that stockpiled vaccines and have already started rolling them out are planning for a post-COVID recovery in the near-term, the bulk of middle-income states will have to wait many months until the vaccine is rolled out to large swaths of the population. Most developing nations, meanwhile, as well as countries that will only get drugs through the global COVAX facility, may still be living with the coronavirus for three more years, according to predictions by The Economist Intelligence Unit. We compare when the pandemic is likely to end in different groups of countries, based on their access to vaccines and rollout plans.

COVID vaccine development could be damaged by politics, says former US Surgeon General

"When we already have enough challenges with people understanding the science behind vaccines, we cannot afford to allow the development and approval of a vaccine to be further politicized," Dr. Vivek Murthy told Ian Bremmer on GZERO World. The former US Surgeon General expressed concerns that politics could hurt the process of development and distribution while shaking public confidence. He also discusses the current state of development for a COVID-19 vaccine, and possible scenarios for its efficacy once available.

Ask an epidemiologist: Harvard's Marc Lipsitch answers your COVID questions

Do masks really protect us? Are children less vulnerable to COVID-19? And why do scientists hope you avoid indoor bars? This week, GZERO World is taking all of our burning questions about the latest in the pandemic to a Harvard epidemiologist. Marc Lipsitch is a Professor in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health and the Director of the Center for Communicable Disease Dynamics. So, he knows his stuff!

Ian Bremmer: The United States isn't Sweden

I don't usually respond directly to individual op-eds but when it's Tom Friedman in The New York Times, and you're talking about how we respond to global coronavirus, well, it seems like it's a good time to weigh in. The op-ed in question: "Is Sweden Doing It Right?" And asking essentially, on the back of that, therefore, should we be Sweden, the United States? Is that the direction that we want to go in? And by the way, do we know what Sweden actually did? And this is really one that you need to take a red pen to.

Read Now Show less

Subscribe to GZERO Media's newsletter, Signal

Latest